Spexis AG has released results from an in vitro study evaluating the effects of combining its potent CXCR4 inhibitor balixafortide (BLX) with several available conventional or targeted therapies in ...
Controlling the morphology of photoactive layers towards nanoscale bi-continuous donor/acceptor interpenetrating networks is a key issue to build high-performance organic solar cells (OSCs). Due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback